AI assistant
Sending…
TherapeuticsMD, Inc. — Director's Dealing 2004
Jan 30, 2004
35134_dirs_2004-01-29_b5580eb8-cc38-4b03-a300-703bab8e24c1.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 5 — Annual Statement of Changes in Beneficial Ownership
Issuer: CROFF ENTERPRISES INC (COFF)
CIK: 0000025743
Period of Report: 2003-12-31
Reporting Person: JENSEN GERALD L (Director, PRESIDENT, 10% Owner)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2003-08-21 | Croff Enterprises, Inc. Common Stock | J | 2358 | $1 | Acquired | 218003 | Direct |
| 2003-09-10 | Croff Enterprises, Inc. Common Stock | J | 12511 | $1 | Acquired | 230514 | Direct |
Footnotes
F1: Acquired by Trust distribution
F2: Includes 132,130 shares of common stock held by Jensen Development Company which is primarily owned by Gerald L. Jensen.
More from TherapeuticsMD, Inc.
Interim / Quarterly Report
2026
May 12
Regulatory Filings
2026
May 12
Major Shareholding Notification
2026
Apr 7
Annual Report
2026
Apr 1
Regulatory Filings
2026
Apr 1
Regulatory Filings
2026
Mar 30
Annual Report
2026
Mar 30
Regulatory Filings
2026
Jan 20
Director's Dealing
2025
Dec 29
Declaration of Voting Results & Voting Rights Announcements
2025
Dec 16